Novocure Ltd

Stock Chart, Company Information, and Scan Results

$12.04(as of Jul 25, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Novocure Ltd Company Information, Fundamentals, and Technical Indicators

Stock Price$12.04
Ticker SymbolNVCR
ExchangeNasdaq
SectorHealthcare
IndustryMedical Devices
Employees1,488
CountyUSA
Market Cap$1,402.0M

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.

Novocure Ltd In Our Stock Scanner

As of Jul 25, 2025
As of ---
As of ---
As of ---
example chart graphic
Scan Name: 52-Week LowScan Type: Stock Fundamentals
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.